Hyman Steven — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Hyman Steven has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Based on the SEC filing context, Steven Hyman is identified as a director of Voyager Therapeutics, Inc. as of the filing date 2026-06-11. Publicly, he is known as a scientist with a background in neuroscience and has been involved in leadership and advisory roles within academia and biomedical research. The available information from the SEC context confirms his role on Voyager's board, while broader biographical details beyond this governance context are not fully established in the filing data provided.
Role
Director
Notability
50/100
Board memberships
Voyager Therapeutics, Inc.
Awards & honors
Listed as a director on Voyager Therapeutics, Inc. according to SEC filings dated 2026-06-11
Based on the SEC filing context, Steven Hyman is identified as a director of Voyager Therapeutics, Inc. as of the filing date 2026-06-11. Publicly, he is known as a scientist with a background in neuroscience and has been involved in leadership and advisory roles within academia and biomedical research. The available information from the SEC context confirms his role on Voyager…
How many SEC Form 4 filings has Hyman Steven submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Hyman Steven's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
